ProKidney Corp - Ordinary Shares - Class A

NASDAQ:PROK   4:00:00 PM EDT
10.49
+0.01 (+0.10%)
4:00:05 PM EDT: $10.49 0.00 (0.00%)
Earnings Announcements

Prokidney Corp Reports Q3 Loss Of $0.13 Per Share

Published: 11/14/2022 11:20 GMT
ProKidney Corp - Ordinary Shares - Class A (PROK) - Prokidney Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights.
Cash and Cash Equivalents As of September 30, 2022, Was $506.3 Million.
Qtrly Loss per Share $0.13.
Q3 Earnings per Share View $-0.24 -- Refinitiv Ibes Data (analyst estimates).
Anticipate Beginning Enrollment in Q1 of 2023 for Proact 2 Global Phase 3 Study.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.25

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.21

More details on our Analysts Page.